Log in
NASDAQ:DCPH

Deciphera Pharmaceuticals SEC Filings & 10K Form

$56.07
+3.50 (+6.66 %)
(As of 09/18/2020 12:00 AM ET)
Add
Compare
Today's Range
$52.77
Now: $56.07
$56.17
50-Day Range
$43.80
MA: $46.30
$52.57
52-Week Range
$31.37
Now: $56.07
$71.11
Volume1.33 million shs
Average Volume306,679 shs
Market Capitalization$3.16 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.84

SEC Filings

Deciphera Pharmaceuticals (NASDAQ:DCPH) SEC Filings

DateFilerForm TypeView
09/10/2020
7:29 PM
Deciphera Pharmaceuticals (Issuer)
Kelly Thomas Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/24/2020
3:00 PM
Deciphera Pharmaceuticals (Issuer)
Hoerter Steven L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/04/2020
4:06 PM
Deciphera Pharmaceuticals (Filer)
Form 424B5
08/04/2020
3:15 PM
Deciphera Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/06/2020
5:16 PM
Deciphera Pharmaceuticals (Issuer)
Taylor Michael Douglas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2020
3:00 PM
Bristol James Arthur (Reporting)
Deciphera Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2020
3:00 PM
Deciphera Pharmaceuticals (Issuer)
Walsh Dennis Leo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2020
3:00 PM
Deciphera Pharmaceuticals (Issuer)
Martin John Richard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2020
3:00 PM
Deciphera Pharmaceuticals (Issuer)
Squarer Ron (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2020
3:00 PM
Deciphera Pharmaceuticals (Issuer)
Taylor Michael Douglas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2020
3:00 PM
Deciphera Pharmaceuticals (Issuer)
Friedman Franklin Stuart (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2020
3:00 PM
Deciphera Pharmaceuticals (Issuer)
Kelley Susan L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2020
3:00 PM
Benz Edward J. JR (Reporting)
Deciphera Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2020
3:00 PM
Allen Patricia L (Reporting)
Deciphera Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2020
4:26 PM
Deciphera Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/13/2020
3:05 PM
Deciphera Pharmaceuticals (Issuer)
Kelly Thomas Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/05/2020
3:13 PM
Deciphera Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/23/2020
3:10 PM
Deciphera Pharmaceuticals (Issuer)
Hoerter Steven L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/13/2020
6:47 PM
Bristol James Arthur (Reporting)
Deciphera Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2020
3:10 PM
Deciphera Pharmaceuticals (Issuer)
Taylor Michael Douglas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2020
4:49 PM
Deciphera Pharmaceuticals (Issuer)
Hoerter Steven L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/09/2020
3:16 PM
Deciphera Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/14/2020
4:16 PM
Deciphera Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2020
4:10 PM
Deciphera Pharmaceuticals (Filer)
Form 424B5
01/28/2020
3:13 PM
Allen Patricia L (Reporting)
Deciphera Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2020
3:10 PM
Deciphera Pharmaceuticals (Issuer)
Martin Daniel C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2020
3:20 PM
Deciphera Pharmaceuticals (Issuer)
Flynn Daniel Lee (Reporting)
Form 4/A
01/21/2020
3:11 PM
Deciphera Pharmaceuticals (Issuer)
Flynn Daniel Lee (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2020
3:10 PM
Deciphera Pharmaceuticals (Issuer)
Morl Christopher John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2020
8:06 AM
Deciphera Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/09/2020
3:10 PM
Deciphera Pharmaceuticals (Issuer)
Morl Christopher John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2019
3:05 PM
Deciphera Pharmaceuticals (Issuer)
Kelly Thomas Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2019
6:08 AM
Deciphera Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/13/2019
4:00 PM
Deciphera Pharmaceuticals (Issuer)
Morl Christopher John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2019
4:00 PM
Deciphera Pharmaceuticals (Issuer)
Flynn Daniel Lee (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2019
3:30 PM
Deciphera Pharmaceuticals (Issuer)
Morl Christopher John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2019
3:10 PM
Deciphera Pharmaceuticals (Issuer)
Flynn Daniel Lee (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2019
3:09 PM
Deciphera Pharmaceuticals (Issuer)
Squarer Ron (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2019
3:05 PM
Deciphera Pharmaceuticals (Issuer)
Squarer Ron (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/05/2019
3:20 PM
Deciphera Pharmaceuticals (Issuer)
Morl Christopher John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2019
3:13 PM
Deciphera Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/26/2019
3:45 PM
Deciphera Pharmaceuticals (Issuer)
Friedman Franklin Stuart (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/26/2019
7:17 AM
Deciphera Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/15/2019
3:24 PM
Deciphera Pharmaceuticals (Subject)
New Leaf Ventures III, L.P. (Filed by)
Form SC 13D/A
11/13/2019
3:41 PM
Deciphera Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/05/2019
3:17 PM
Deciphera Pharmaceuticals (Issuer)
Taylor Michael Douglas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2019
3:16 PM
Bristol James Arthur (Reporting)
Deciphera Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/04/2019
4:16 PM
Deciphera Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/29/2019
3:02 PM
Deciphera Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/22/2019
4:13 PM
Deciphera Pharmaceuticals (Subject)
INTEGRATED CORE STRATEGIES LLC (0001319244) (Filed by)
Form SC 13G
10/17/2019
3:35 PM
Deciphera Pharmaceuticals (Issuer)
Sherman Matthew L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/08/2019
3:21 PM
Deciphera Pharmaceuticals (Issuer)
Sherman Matthew L (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/30/2019
8:20 AM
Deciphera Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/23/2019
3:03 PM
Deciphera Pharmaceuticals (Issuer)
Martin Daniel C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2019
3:04 PM
Deciphera Pharmaceuticals (Issuer)
Kelly Thomas Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2019
3:03 PM
Deciphera Pharmaceuticals (Issuer)
Taylor Michael Douglas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2019
3:15 PM
Deciphera Pharmaceuticals (Issuer)
Taylor Michael Douglas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/26/2019
4:27 PM
Deciphera Pharmaceuticals (Subject)
New Leaf Venture Management III, L.L.C. (Filed by)
Form SC 13D/A
08/19/2019
3:35 PM
Deciphera Pharmaceuticals (Issuer)
New Leaf Biopharma Opportunities I, L.P. (Reporting)
New Leaf BPO Associates I, L.P. (Reporting)
New Leaf Venture Associates III, L.P. (Reporting)
New Leaf Venture Management III, L.L.C. (Reporting)
New Leaf Ventures III, L.P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2019
4:14 PM
Deciphera Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/15/2019
4:13 PM
Deciphera Pharmaceuticals (Filer)
Form 424B5
08/14/2019
8:19 PM
Deciphera Pharmaceuticals (Filer)
Form S-3MEF
08/13/2019
6:57 PM
Deciphera Pharmaceuticals (Issuer)
Taylor Michael Douglas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2019
6:55 PM
Deciphera Pharmaceuticals (Issuer)
Kelly Thomas Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2019
6:52 PM
Deciphera Pharmaceuticals (Issuer)
Flynn Daniel Lee (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2019
6:51 PM
Bristol James Arthur (Reporting)
Deciphera Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2019
3:18 PM
Deciphera Pharmaceuticals (Filer)
Form 424B5
08/13/2019
6:12 AM
Deciphera Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/02/2019
6:15 AM
Deciphera Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/02/2019
6:11 AM
Deciphera Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/08/2019
5:31 PM
Deciphera Pharmaceuticals (Issuer)
Kelley Susan L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2019
5:30 PM
Deciphera Pharmaceuticals (Issuer)
Kelley Susan L. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/08/2019
3:18 PM
Deciphera Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/21/2019
3:03 PM
Deciphera Pharmaceuticals (Issuer)
Kelly Thomas Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2019
5:33 PM
Deciphera Pharmaceuticals (Issuer)
Ross Michael Jay (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2019
3:37 PM
Deciphera Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/13/2019
3:14 PM
Deciphera Pharmaceuticals (Issuer)
Walsh Dennis Leo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2019
3:11 PM
Deciphera Pharmaceuticals (Issuer)
Martin John Richard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2019
3:11 PM
Bristol James Arthur (Reporting)
Deciphera Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2019
3:10 PM
Benz Edward J. JR (Reporting)
Deciphera Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2019
3:10 PM
Allen Patricia L (Reporting)
Deciphera Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2019
6:12 AM
Deciphera Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/05/2019
3:08 PM
Deciphera Pharmaceuticals (Issuer)
Kelly Thomas Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2019
3:04 PM
Deciphera Pharmaceuticals (Issuer)
Kelly Thomas Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2019
3:21 PM
Deciphera Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/09/2019
3:16 PM
Deciphera Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/22/2019
3:08 PM
Deciphera Pharmaceuticals (Filer)
Form DEFA14A
04/22/2019
3:06 PM
Deciphera Pharmaceuticals (Filer)
Form DEF 14A
03/20/2019
4:49 PM
Deciphera Pharmaceuticals (Issuer)
Flynn Daniel Lee (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2019
4:47 PM
Deciphera Pharmaceuticals (Issuer)
Hoerter Steven L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2019
3:15 PM
Deciphera Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/14/2019
3:12 PM
Deciphera Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/14/2019
3:09 PM
Deciphera Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/04/2019
3:30 PM
Deciphera Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/20/2019
7:37 PM
Deciphera Pharmaceuticals (Issuer)
Kelly Thomas Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2019
6:25 PM
Bristol James Arthur (Reporting)
Deciphera Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2019
6:24 PM
Deciphera Pharmaceuticals (Issuer)
Taylor Michael Douglas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2019
3:09 PM
Bristol James Arthur (Reporting)
Deciphera Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2019
3:04 PM
Deciphera Pharmaceuticals (Issuer)
Taylor Michael Douglas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/01/2019
3:21 PM
Deciphera Pharmaceuticals (Issuer)
Taylor Michael Douglas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 9/20/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.